Publication Results

Generate Report

Add publications by marking their checkboxes, or

Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer.

Zhang Q,  Li R,  Chen X,  Lee SB,  Pan J,  Xiong D,  Hu J,  Miller MS,  Szabo E,  Lubet RA,  Wang Y,  You M
Oncotarget 2017 Sep 22;8(42):72447-72456
PubMed ID: 29069801
PMC ID: PMC5641144
Groups or Programs: Chemopreventive Agent DevelopmentLung and Upper Aerodigestive Cancer

Pioglitazone-mediated reversal of elevated glucose metabolism in the airway epithelium of mouse lung adenocarcinomas.

Xiong D,  Pan J,  Zhang Q,  Szabo E,  Miller MS,  Lubet RA,  Wang Y,  You M
JCI Insight 2017 Jul 6;2(13)
PubMed ID: 28679956
PMC ID: PMC5499364
Groups or Programs: Chemopreventive Agent DevelopmentLung and Upper Aerodigestive Cancer

Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.

Xiong D,  Pan J,  Zhang Q,  Szabo E,  Miller MS,  Lubet RA,  You M,  Wang Y
Oncotarget 2017 Mar 21;8(12):18885-18900
PubMed ID: 27935865
PMC ID: PMC5386655
Groups or Programs: Chemopreventive Agent DevelopmentLung and Upper Aerodigestive Cancer

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.

Carter CA,  Rajan A,  Keen C,  Szabo E,  Khozin S,  Thomas A,  Brzezniak C,  Guha U,  Doyle LA,  Steinberg SM,  Xi L,  Raffeld M,  Tomita Y,  Lee MJ,  Lee S,  Trepel JB,  Reckamp KL,  Koehler S,  Gitlitz B,  Salgia R,  Gandara D,  Vokes E,  Giaccone G
Ann Oncol 2016 Apr;27(4):693-9
PubMed ID: 26802155
PMC ID: PMC4803455
Groups or Programs: Lung and Upper Aerodigestive Cancer

Repurposing old drugs to chemoprevention: the case of metformin.

Heckman-Stoddard BM,  Gandini S,  Puntoni M,  Dunn BK,  DeCensi A,  Szabo E
Semin Oncol 2016 Feb;43(1):123-133
PubMed ID: 26970131
PMC ID: PMC4789107
Groups or Programs: Breast and Gynecologic CancerChemopreventive Agent DevelopmentLung and Upper Aerodigestive Cancer

Immunologic approaches to cancer prevention-current status, challenges, and future perspectives.

Wojtowicz ME,  Dunn BK,  Umar A
Semin Oncol 2016 Feb;43(1):161-172
PubMed ID: 26970135
PMC ID: not available
Groups or Programs: Chemopreventive Agent DevelopmentGastrointestinal and Other CancersLung and Upper Aerodigestive Cancer

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

Kensler TW,  Spira A,  Garber JE,  Szabo E,  Lee JJ,  Dong Z,  Dannenberg AJ,  Hait WN,  Blackburn E,  Davidson NE,  Foti M,  Lippman SM
Cancer Prev Res (Phila) 2016 Jan;9(1):2-10
PubMed ID: 26744449
PMC ID: PMC4955753
Groups or Programs: Lung and Upper Aerodigestive Cancer

Preinvasive Endobronchial Lesions: Lung Cancer Precursors and Risk Markers?

Lam S,  Szabo E
Am J Respir Crit Care Med 2015 Dec 15;192(12):1411-3
PubMed ID: 26669471
PMC ID: PMC4731725
Groups or Programs: Lung and Upper Aerodigestive Cancer

AACR Cancer Progress Report 2015.

Baselga J,  Bhardwaj N,  Cantley LC,  DeMatteo R,  DuBois RN,  Foti M,  Gapstur SM,  Hahn WC,  Helman LJ,  Jensen RA,  Paskett ED,  Lawrence TS,  Lutzker SG,  Szabo E
Clin Cancer Res 2015 Oct 1;21(19 Suppl):S1-128
PubMed ID: 26429991
PMC ID: PMC5001568
Groups or Programs: Lung and Upper Aerodigestive Cancer

A Randomized Phase IIb Trial of Myo-Inositol in Smokers with Bronchial Dysplasia

Lam Stephen,  Mandrekar Sumithra,  Ziegler Katie Allen,  Seisler Drew,  Midthun David,  Mao Jenny,  Aubry Marie Christine,  McWilliams Annette,  Sin Don,  Shaipanich Tawimas,  Spira Avrum,  Ionescu Diana,  Mayo John,  Yi Joanne Eunhee,  Tazelaar Henry,  Harmsen William,  Smith Judith,  Limburg Paul,  Szabo Eva
J Thorac Oncol 2015 Sep;10(9, Suppl 2):S218, Abstract ORAL23.01
PubMed ID: not available
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Molecular cancer prevention: Current status and future directions.

Maresso KC,  Tsai KY,  Brown PH,  Szabo E,  Lippman S,  Hawk ET
CA Cancer J Clin 2015 Sep-Oct;65(5):345-83
PubMed ID: 26284997
PMC ID: PMC4820069
Groups or Programs: Lung and Upper Aerodigestive Cancer

A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.

Morgan TR,  Osann K,  Bottiglieri T,  Pimstone N,  Hoefs JC,  Hu KQ,  Hassanein T,  Boyer TD,  Kong L,  Chen WP,  Richmond E,  Gonzalez R,  Rodriguez LM,  Meyskens FL
Cancer Prev Res (Phila) 2015 Sep;8(9):864-72
PubMed ID: 26130251
PMC ID: PMC4560676
Groups or Programs: Gastrointestinal and Other CancersLung and Upper Aerodigestive Cancer

Chemoprevention Clinical Trials: How Do We Move Forward? How Do We Identify Valid End Points?

Szabo Eva
J Thorac Oncol 2015 Sep;10(9, Suppl 2):S113-S113
PubMed ID: not available
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Screening for Small Cell Lung Cancer: Analysis of the National Lung Cancer Screening Trial Data

Thomas Anish,  Szabo Eva,  Pinsky Paul
J Thorac Oncol 2015 Sep;10(9, Suppl 2):S221, Abstract ORAL25.01
PubMed ID: not available
PMC ID: not available
Groups or Programs: Early DetectionLung and Upper Aerodigestive Cancer

Implications of the "Bad Luck" Explanation of Cancer Risk for the Field of Cancer Prevention.

Wang TC,  Szabo E
Cancer Prev Res (Phila) 2015 Sep;8(9):761
PubMed ID: 26174321
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Chemoprevention Trials: Past, Present, and Future

Wigle Dennis,  Szabo Eva,  Spira Avrum
J Thorac Oncol 2015 Sep;10(9, Suppl 2):S151, Abstract MTE18.01
PubMed ID: not available
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Framework for clinical evaluation of chemopreventive agents: Defining criteria for future assessment

Walsh Naomi,  Alberts David S.,  Brown Powel,  Limburg Paul,  Sherman Mark,  Szabo Eva
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 4662
PubMed ID: not available
PMC ID: not available
Groups or Programs: Breast and Gynecologic CancerLung and Upper Aerodigestive Cancer

Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.

Hershman DL,  Unger JM,  Crew KD,  Awad D,  Dakhil SR,  Gralow J,  Greenlee H,  Lew DL,  Minasian LM,  Till C,  Wade JL 3rd,  Meyskens FL,  Moinpour CM
J Clin Oncol 2015 Jun 10;33(17):1910-7
PubMed ID: 25940724
PMC ID: PMC4451174
Groups or Programs: Lung and Upper Aerodigestive Cancer ;  Office of the Director

Standardizing measurement of tobacco use in cancer clinical trials

Land Stephanie R.,  Warren Graham Walter,  Moinpour Carol,  Ostroff Jamie S.,  Crafts Jennifer,  Folz Jasmine,  Gulley James L.,  Szabo Eva,  Chollette Veronica,  Brandon Thomas H.,  Duffy Sonia,  Hatsukami Dorothy K.,  Dresler Carolyn M.,  Gritz Ellen R.,  Schnoll Robert,  Sarna Linda,  Rigotti Nancy,  Buckner Jan C.,  Mitchell Sandra A.,  Toll Benjamin
J Clin Oncol 2015 May 20;33(15):Abstract e17658
PubMed ID: not available
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

A pilot, single arm, prospective trial using neoadjuvant rapamycin prior to definitive therapy in head and neck squamous cell carcinoma

Shirai Keisuke,  Day Terry A.,  Szabo Eva,  Van Waes Carter,  O'Brien Paul E.,  Matheus Maria Gisele,  Godwin Kristina,  Sood Amit J.,  Vick Julie A.,  Martin Daniel,  Vitale-Cross Lynn,  Molinolo Alfredo,  Gutkind Jorge Silvio
J Clin Oncol 2015 May 20;33(15):Abstract 6071
PubMed ID: not available
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

Lopez-Chavez A,  Thomas A,  Rajan A,  Raffeld M,  Morrow B,  Kelly R,  Carter CA,  Guha U,  Killian K,  Lau CC,  Abdullaev Z,  Xi L,  Pack S,  Meltzer PS,  Corless CL,  Sandler A,  Beadling C,  Warrick A,  Liewehr DJ,  Steinberg SM,  Berman A,  Doyle A,  Szabo E,  Wang Y,  Giaccone G
J Clin Oncol 2015 Mar 20;33(9):1000-7
PubMed ID: 25667274
PMC ID: PMC4356709
Groups or Programs: Lung and Upper Aerodigestive Cancer

A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.

Gillen DL,  Meyskens FL,  Morgan TR,  Zell JA,  Carroll R,  Benya R,  Chen WP,  Mo A,  Tucker C,  Bhattacharya A,  Huang Z,  Arcilla M,  Wong V,  Chung J,  Gonzalez R,  Rodriguez LM,  Szabo E,  Rosenberg DW,  Lipkin SM
Cancer Prev Res (Phila) 2015 Mar;8(3):222-30
PubMed ID: 25604134
PMC ID: PMC4355051
Groups or Programs: Gastrointestinal and Other CancersLung and Upper Aerodigestive Cancer

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

Thomas A,  Rajan A,  Berman A,  Tomita Y,  Brzezniak C,  Lee MJ,  Lee S,  Ling A,  Spittler AJ,  Carter CA,  Guha U,  Wang Y,  Szabo E,  Meltzer P,  Steinberg SM,  Trepel JB,  Loehrer PJ,  Giaccone G
Lancet Oncol 2015 Feb;16(2):177-86
PubMed ID: 25592632
PMC ID: PMC4401497
Groups or Programs: Lung and Upper Aerodigestive Cancer

Dermatomyositis paraneoplastic syndrome before symptomatic tonsillar squamous cell carcinoma: a case report.

Adi AH,  Alturkmani H,  Spock T,  Williams Yohannes P,  Wargo S,  Szabo E,  Gutkind JS,  Van Waes C
Head Neck 2015 Jan;37(1):E1-3
PubMed ID: 24715579
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Cuzick J,  Thorat MA,  Bosetti C,  Brown PH,  Burn J,  Cook NR,  Ford LG,  Jacobs EJ,  Jankowski JA,  La Vecchia C,  Law M,  Meyskens F,  Rothwell PM,  Senn HJ,  Umar A
Ann Oncol 2015 Jan;26(1):47-57
PubMed ID: 25096604
PMC ID: PMC4269341
Groups or Programs: Gastrointestinal and Other CancersLung and Upper Aerodigestive Cancer ;  Office of the Director

Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT.

Pinsky PF,  Nath PH,  Gierada DS,  Sonavane S,  Szabo E
Cancer Prev Res (Phila) 2014 Dec;7(12):1179-85
PubMed ID: 24755313
PMC ID: PMC4206664
Groups or Programs: Early DetectionLung and Upper Aerodigestive Cancer

PPARγ in head and neck cancer prevention.

Burotto M,  Szabo E
Oral Oncol 2014 Oct;50(10):924-9
PubMed ID: 24434068
PMC ID: PMC4096621
Groups or Programs: Lung and Upper Aerodigestive Cancer

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.

Gandini S,  Puntoni M,  Heckman-Stoddard BM,  Dunn BK,  Ford L,  DeCensi A,  Szabo E
Cancer Prev Res (Phila) 2014 Sep;7(9):867-85
PubMed ID: 24985407
PMC ID: PMC4154969
Groups or Programs: Breast and Gynecologic CancerChemopreventive Agent DevelopmentLung and Upper Aerodigestive Cancer

Images in clinical medicine. Sunitinib-associated hair depigmentation.

Brzezniak C,  Szabo E
N Engl J Med 2014 Apr 24;370(17):e27
PubMed ID: 24758639
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors.

Rahma OE,  Hamilton JM,  Wojtowicz M,  Dakheel O,  Bernstein S,  Liewehr DJ,  Steinberg SM,  Khleif SN
J Transl Med 2014 Feb 24;12:55
PubMed ID: 24565030
PMC ID: PMC3942063
Groups or Programs: Lung and Upper Aerodigestive Cancer

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.

Rajan A,  Carter CA,  Berman A,  Cao L,  Kelly RJ,  Thomas A,  Khozin S,  Chavez AL,  Bergagnini I,  Scepura B,  Szabo E,  Lee MJ,  Trepel JB,  Browne SK,  Rosen LB,  Yu Y,  Steinberg SM,  Chen HX,  Riely GJ,  Giaccone G
Lancet Oncol 2014 Feb;15(2):191-200
PubMed ID: 24439931
PMC ID: PMC3954701
Groups or Programs: Lung and Upper Aerodigestive Cancer

Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer.

Hecht SS,  Szabo E
Cancer Prev Res (Phila) 2014 Jan;7(1):1-8
PubMed ID: 24403288
PMC ID: PMC4296669
Groups or Programs: Lung and Upper Aerodigestive Cancer

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

Kelly RJ,  Thomas A,  Rajan A,  Chun G,  Lopez-Chavez A,  Szabo E,  Spencer S,  Carter CA,  Guha U,  Khozin S,  Poondru S,  Van Sant C,  Keating A,  Steinberg SM,  Figg W,  Giaccone G
Ann Oncol 2013 Oct;24(10):2601-6
PubMed ID: 23857959
PMC ID: PMC3784336
Groups or Programs: Lung and Upper Aerodigestive Cancer

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.

Wong SJ,  Campbell B,  Massey B,  Lynch DP,  Cohen EEW,  Blair E,  Selle R,  Shklovskaya J,  Jovanovic BD,  Skripkauskas S,  Dew A,  Kulesza P,  Parimi V,  Bergan RC,  Szabo E
Oral Oncol 2013 Sep;49(9):970-976
PubMed ID: 23845699
PMC ID: PMC4456032
Groups or Programs: Phase 0/I/II TrialsLung and Upper Aerodigestive Cancer

Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.

Mohebati A,  Milne GL,  Zhou XK,  Duffield-Lillico AJ,  Boyle JO,  Knutson A,  Bosworth BP,  Kingsley PJ,  Marnett LJ,  Brown PH,  Akpa EG,  Szabo E,  Dannenberg AJ
Cancer Prev Res (Phila) 2013 Jul;6(7):646-55
PubMed ID: 23682075
PMC ID: PMC3707304
Groups or Programs: Phase 0/I/II TrialsLung and Upper Aerodigestive Cancer

Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.

Thomas A,  Xi L,  Carter CA,  Rajan A,  Khozin S,  Szabo E,  Dennis PA,  Giaccone G,  Raffeld M
Clin Lung Cancer 2013 Jul;14(4):452-6
PubMed ID: 23540867
PMC ID: PMC5002228
Groups or Programs: Lung and Upper Aerodigestive Cancer

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Cuzick J,  Sestak I,  Bonanni B,  Costantino JP,  Cummings S,  DeCensi A,  Dowsett M,  Forbes JF,  Ford L,  LaCroix AZ,  Mershon J,  Mitlak BH,  Powles T,  Veronesi U,  Vogel V,  Wickerham DL,  SERM Chemoprevention of Breast Cancer Overview Group
Lancet 2013 May 25;381(9880):1827-34
PubMed ID: 23639488
PMC ID: PMC3671272
Groups or Programs: Lung and Upper Aerodigestive CancerCommunity Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.

Lubet RA,  Szabo E,  Iwata KK,  Gill SC,  Tucker C,  Bode A,  Steele VE,  Juliana MM,  Nicastro HL,  Grubbs CJ
Cancer Prev Res (Phila) 2013 May;6(5):448-54
PubMed ID: 23531447
PMC ID: PMC3813957
Groups or Programs: Lung and Upper Aerodigestive CancerChemopreventive Agent Development

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Szabo E,  Mao JT,  Lam S,  Reid ME,  Keith RL
Chest 2013 May;143(5 Suppl):e40S-e60S
PubMed ID: 23649449
PMC ID: PMC3749715
Groups or Programs: Lung and Upper Aerodigestive Cancer

Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjects.

Berg AK,  Mandrekar SJ,  Ziegler KL,  Carlson EC,  Szabo E,  Ames MM,  Boring D,  Limburg PJ,  Reid JM,  Cancer Prevention Network
J Clin Pharmacol 2013 Apr;53(4):403-12
PubMed ID: 23436338
PMC ID: PMC4120995
Groups or Programs: Phase 0/I/II TrialsLung and Upper Aerodigestive CancerChemopreventive Agent Development

18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.

Thomas A,  Mena E,  Kurdziel K,  Venzon D,  Khozin S,  Berman AW,  Choyke P,  Szabo E,  Rajan A,  Giaccone G
Clin Cancer Res 2013 Mar 15;19(6):1487-93
PubMed ID: 23382114
PMC ID: PMC3602145
Groups or Programs: Lung and Upper Aerodigestive Cancer

Randomized phase II trial of sulindac for lung cancer chemoprevention.

Limburg PJ,  Mandrekar SJ,  Aubry MC,  Ziegler KL,  Zhang J,  Yi JE,  Henry M,  Tazelaar HD,  Lam S,  McWilliams A,  Midthun DE,  Edell ES,  Rickman OB,  Mazzone P,  Tockman M,  Beamis JF,  Lamb C,  Simoff M,  Loprinzi C,  Szabo E,  Jett J,  Cancer Prevention Network
Lung Cancer 2013 Mar;79(3):254-61
PubMed ID: 23261228
PMC ID: PMC3566344
Groups or Programs: Phase 0/I/II TrialsLung and Upper Aerodigestive Cancer

Characterization and management of cardiac involvement of thymic epithelial tumors.

Thomas A,  Shanbhag S,  Haglund K,  Berman A,  Jakopovic M,  Szabo E,  Arai A,  Schrump DS,  Kwong KF,  Rajan A,  Giaccone G
J Thorac Oncol 2013 Feb;8(2):246-9
PubMed ID: 23328550
PMC ID: PMC3552332
Groups or Programs: Lung and Upper Aerodigestive Cancer

Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.

Wang Y,  Yao R,  Gao S,  Wen W,  Du Y,  Szabo E,  Hu M,  Lubet RA,  You M
Mol Carcinog 2013 Jan;52(1):49-56
PubMed ID: 22086836
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive CancerChemopreventive Agent Development

Validation of LOH profiles for assessing oral cancer risk.

Lingen MW,  Szabo E
Cancer Prev Res (Phila) 2012 Sep;5(9):1075-7
PubMed ID: 22911110
PMC ID: PMC3435466
Groups or Programs: Lung and Upper Aerodigestive Cancer

A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers.

Mohebati A,  Knutson A,  Zhou XK,  Smith JJ,  Brown PH,  Dannenberg AJ,  Szabo E
Contemp Clin Trials 2012 Sep;33(5):942-8
PubMed ID: 22771576
PMC ID: PMC3460548
Groups or Programs: Phase 0/I/II TrialsLung and Upper Aerodigestive Cancer

A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.

Rajan A,  Carter CA,  Kelly RJ,  Gutierrez M,  Kummar S,  Szabo E,  Yancey MA,  Ji J,  Mannargudi B,  Woo S,  Spencer S,  Figg WD,  Giaccone G
Clin Cancer Res 2012 Apr 15;18(8):2344-51
PubMed ID: 22371451
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.

Kelly RJ,  Lopez-Chavez A,  Szabo E
Curr Drug Targets 2011 Dec;12(13):1983-8
PubMed ID: 21158704
PMC ID: not available
Groups or Programs: Lung and Upper Aerodigestive Cancer

Lung cancer chemoprevention with celecoxib in former smokers.

Mao JT,  Roth MD,  Fishbein MC,  Aberle DR,  Zhang ZF,  Rao JY,  Tashkin DP,  Goodglick L,  Holmes EC,  Cameron RB,  Dubinett SM,  Elashoff R,  Szabo E,  Elashoff D
Cancer Prev Res (Phila) 2011 Jul;4(7):984-93
PubMed ID: 21733822
PMC ID: PMC3153413
Groups or Programs: Lung and Upper Aerodigestive Cancer

Altered histology provides a positive clinical signal in the bronchial epithelium.

Szabo E
Cancer Prev Res (Phila) 2011 Jun;4(6):775-8
PubMed ID: 21636542
PMC ID: PMC3110761
Groups or Programs: Lung and Upper Aerodigestive Cancer